Anixa Biosciences
ANIX
ANIX
42 hedge funds and large institutions have $10.2M invested in Anixa Biosciences in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
33% less capital invested
Capital invested by funds: $15.2M → $10.2M (-$4.95M)
Holders
42
Holding in Top 10
–
Calls
$122K
Puts
$85K
Top Buyers
| 1 | +$352K | |
| 2 | +$77K | |
| 3 | +$58.6K | |
| 4 |
Goldman Sachs
New York
|
+$49K |
| 5 |
VF
Virtu Financial
New York
|
+$48.9K |
Top Sellers
| 1 | -$78.6K | |
| 2 | -$78K | |
| 3 | -$46.6K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$16.1K |
| 5 |
BlackRock
New York
|
-$15.2K |